Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anaemia.
Bessho
M
M
First Department of Internal Medicine, Saitama Medical School, Japan.
Toyoda
A
A
Itoh
Y
Y
Sakata
T
T
Kawai
N
N
Jinnai
I
I
Saito
M
M
Hirashima
K
K
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000097:blood / Q000628:therapy*; D004906:Erythrocyte Count; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D010976:Platelet Count; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012156:Reticulocytes / Q000473:pathology
D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor